Partner Content Partner Content Explore the future of ocular gene editing and strategic drug... Ophthalmic Drugs Conference
Partner Content Partner Content SMi’s Europe’s Leading Ophthalmic Conference is only 3 weeks... Europe's Leading Ophthalmic Conference
Partner Content Partner Content SMi’s Ophthalmic Drugs Conference is only 4 weeks away! Only 4 Weeks Remain for Ophthalmic Drugs
Partner Content Partner Content Spotlight on Key Sessions at Ophthalmic Drugs this November Sessions at Ophthalmic Drugs
Partner Content Partner Content Exceptional speaker line-up for Ophthalmic Drugs Hear from Santen, Novaliq GmBh, Aptar Pharma and more
News UK is first European country to approve Lilly's Foundayo Eli Lilly's oral GLP-1 agonist Foundayo has been approved for weight management and type 2 diabetes in the UK, its first European market.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
